Skip to main content
ENHA
NYSE Life Sciences

Enhanced Group Board Approves 1-for-10 Reverse Split, Effective Late October

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Neutral
Importance info
7
Price
$1.48
Mkt Cap
$604.925M
52W Low
$1.4
52W High
$14
52W Position info
5.7% above low
Off High info
89% below high
Rel. Volume info
2.6× avg
Market data snapshot near publication time

ENHA is trading near its 52-week low of $1.4 (5.7% above the low) on elevated volume (2.6× avg).

Summary

The board approved a 1-for-10 reverse stock split of Class A and Class B shares, effective on or around October 28, 2026. Controlling shareholder Enhanced Holdings LP, via Apeiron Investment Group, approved the split by written consent on September 28, 2026, holding 96.6% voting power. No further shareholder approval is needed. The company says the move is proactive, not driven by NYSE listing deficiencies, and aims to improve marketability to institutional investors. This follows a period of heavy insider buying by chairman Christian Angermayer, who recently resigned from the board, and a going concern warning in the latest 10-Q. The split will not change ownership percentages or voting power. Watch for the official split-adjusted trading date and updated CUSIP announcement.

Updated with an SEC PRE 14C filing · What changed

Updates

  1. · SEC PRE 14C — Controlling shareholder Enhanced Holdings LP, via Apeiron Investment Group, approved the 1-for-10 reverse split by written consent on September 28, 2026, holding 96.6% voting power.

At the time of this announcement, ENHA was trading at $1.48 on NYSE in the Life Sciences sector, with a market capitalization of approximately $604.9M. The 52-week trading range was $1.40 to $14.00. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

ENHA - Latest Insights

ENHA
Oct 01, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.44
Real-time Price: $1.46 info
Change: +$0.0202 (+1%) info
Market Cap: $581.612M info
ENHA
Sep 29, 2026, 9:36 AM EDT
Filing Type: PRE 14C
Importance Score:
7
Price at Filing: $1.48
Real-time Price: $1.46 info
Change: -$0.0148 (-1%) info
Market Cap: $581.612M info
ENHA
Sep 28, 2026, 6:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.54
Real-time Price: $1.46 info
Change: -$0.0798 (-5%) info
Market Cap: $581.612M info
ENHA
Sep 23, 2026, 8:27 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $1.40
Real-time Price: $1.46 info
Change: +$0.0554 (+4%) info
Market Cap: $581.612M info
ENHA
Sep 23, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.40
Real-time Price: $1.46 info
Change: +$0.0602 (+4%) info
Market Cap: $581.612M info